Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum‐based adjuvant chemotherapy

Volumetric parameters of positron emission tomography–computed tomography using 18F‐fludeoxyglucose (18F‐FDG PET/CT) that comprehensively reflect both metabolic activity and tumor burden are capable of predicting survival in several cancers. The aim of this study was to investigate the predictive pe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer science 2016-04, Vol.107 (4), p.478-485
Hauptverfasser:	Yamamoto, Makoto, Tsujikawa, Tetsuya, Fujita, Yuko, Chino, Yoko, Kurokawa, Tetsuji, Kiyono, Yasushi, Okazawa, Hidehiko, Yoshida, Yoshio
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Cancer therapies Carboplatin - administration & dosage Chemotherapy Chemotherapy, Adjuvant Computed tomography Disease-Free Survival Epithelial ovarian cancer Female Fluorodeoxyglucose F18 - administration & dosage Glycolysis Glycolysis - drug effects Humans Kaplan-Meier Estimate Medical imaging Medical prognosis Medical records metabolic tumor burden metabolic tumor volume Metabolism Middle Aged Multivariate analysis Original Ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - metabolism Ovarian Neoplasms - pathology Paclitaxel - administration & dosage Patients Platinum Positron emission tomography positron emission tomography–computed tomography using 18F‐fludeoxyglucose Prognosis Risk factors Scanners Statistical analysis Surgery Survival Tomography total lesion glycolysis Tumor Burden - drug effects Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!